Perceptions of Hepatitis C Screening and Treatment among People with Illicit Drug Use

Despite the existence of effective treatment options, people with illicit drug use are less likely to be screened and treated for hepatitis C virus (HCV) than those without drug use. This disparity is especially pronounced among racial and ethnic minorities. The purpose of this qualitative study was to explore attitudes, perceptions, and experiences regarding HCV testing, referral, and treatment among racial and ethnic minorities with drug use. Ninety-five participants recruited from HIV primary care clinics, methadone maintenance programs, and syringe exchange programs in New York and San Francisco were included in 14 focus groups.

• Many participants were tested at their treatment facility but were unaware of other voluntary testing sites.
• Receipt of a positive test was often accompanied by an unclear message about next steps.
• Many subjects perceived a lack of need for treatment due to asymptomatic state, health care messages minimizing the severity of the disease, and inadequate recommendations for treatment by health care professionals.
• Social networks and interactions with peers were a common source of HCV-related information.

Comments:

Although people with illicit drug use have a high prevalence of HCV, testing and treatment are not always offered to this population. Inconsistent health care messages regarding the natural history of the disease contribute to a lack of understanding among patients. Standardization of public health messages—including those delivered via social networking, peer support groups, and post-test counseling—may improve the general understanding of the natural history and treatment of HCV among people with drug use.

Jeanette M. Tetrault, MD

Reference:

Jordan AE, Masson CL, Mateu-Gelabert P, et al. Perceptions of drug users regarding hepatitis C screening and care: a qualitative study. Harm Reduct J. 2013;10:10.